Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study.
Pierga JY, Petit T, Delozier T, Ferrero JM, Campone M, Gligorov J, Lerebours F, Roché H, Bachelot T, Charafe-Jauffret E, Pavlyuk M, Kraemer S, Bidard FC, Viens P. Pierga JY, et al. Among authors: bidard fc. Lancet Oncol. 2012 Apr;13(4):375-84. doi: 10.1016/S1470-2045(12)70049-9. Epub 2012 Feb 28. Lancet Oncol. 2012. PMID: 22377126 Clinical Trial.
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.
André T, Tournigand C, Mineur L, Fellague-Chebra R, Flesch M, Mabro M, Hebbar M, Postel Vinay S, Bidard FC, Louvet C, de Gramont A. André T, et al. Among authors: bidard fc. Ann Oncol. 2007 Jan;18(1):77-81. doi: 10.1093/annonc/mdl336. Epub 2006 Oct 9. Ann Oncol. 2007. PMID: 17030548 Free article. Clinical Trial.
Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.
Pierga JY, Bidard FC, Mathiot C, Brain E, Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A, Marty M. Pierga JY, et al. Among authors: bidard fc. Clin Cancer Res. 2008 Nov 1;14(21):7004-10. doi: 10.1158/1078-0432.CCR-08-0030. Clin Cancer Res. 2008. PMID: 18980996
Meningeal carcinomatosis in HER2-overexpressing breast cancers.
Bidard FC, Guilhaume MN, Gauthier H, Cottu PH, Diéras V, Pierga JY. Bidard FC, et al. J Neurooncol. 2009 Jun;93(2):287-8. doi: 10.1007/s11060-008-9768-1. Epub 2009 Jan 13. J Neurooncol. 2009. PMID: 19139826 No abstract available.
Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma.
Vincent-Salomon A, Caly M, De Rycke Y, Fréneaux P, Klijanienko J, Laé M, Viard F, Nos C, Bidard FC, Alran S, Salmon R, Kirova Y, Pierga JY, Sigal-Zafrani B, Sastre-Garau X. Vincent-Salomon A, et al. Among authors: bidard fc. Eur J Cancer. 2009 Jul;45(11):1979-86. doi: 10.1016/j.ejca.2009.03.015. Epub 2009 Apr 15. Eur J Cancer. 2009. PMID: 19375305
202 results